Manipal Health Enterprises IPO GMP History
Manipal Health Enterprises IPO has been listed on August 5, 2026 at a listing price of ₹652, against the issue price of ₹590 — a gain of ₹62 (+10.51%). The GMP peaked at ₹35 on 24 July 2026 and reached a low of ₹-15 on 1 August 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Manipal Health Enterprises IPO raised ₹9275.22 Cr. through its IPO at a price band of ₹560 to ₹590 per share, with a lot size of 25 shares. The IPO was open for subscription from 29 Jul 2026 to 31 Jul 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 8 Sep, 1:37 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 05 Aug 2026 | ₹ 3 | — | 0.51% | — | — |
| 04 Aug 2026 | ₹ 3 | ▲ | 0.51% | — | — |
| 03 Aug 2026 | ₹ -6 | ▲ | -1.02% | — | — |
| 01 Aug 2026 | ₹ -15 | — | -2.5% | — | — |
| 31 Jul 2026 | ₹ -15 | ▼ | -2.5% | — | — |
| 30 Jul 2026 | ₹ 6 | ▼ | 1.0% | — | — |
| 29 Jul 2026 | ₹ 9 | ▼ | 1.5% | — | — |
| 28 Jul 2026 | ₹ 9.5 | ▼ | 1.6% | — | — |
| 27 Jul 2026 | ₹ 13 | ▼ | 2.2% | — | — |
| 26 Jul 2026 | ₹ 25 | — | 4.2% | — | — |
| 25 Jul 2026 | ₹ 25 | ▼ | 4.2% | — | — |
| 24 Jul 2026 | ₹ 35 | — | 5.9% | — | — |
Manipal Health Enterprises IPO dates
Key dates from opening to listing. Today is 23 October.
- Open 29 Jul 2026
- Close 31 Jul 2026
- Allotment 03 Aug 2026
- Refund/credit 04 Aug 2026
- Listing 05 Aug 2026
Manipal Health Enterprises IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹590 |
|---|---|
| GMP-based estimate (pre-listing) | ₹593 (+0.5%) |
| Listing gain / loss | +₹62 per share |
| Listing date | 05 Aug, 2026 |
| Actual listing price | ₹652 (+10.51%) |
Is Manipal Health Enterprises IPO GMP reliable?
Grey market premium for Manipal Health Enterprises IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Manipal Health Enterprises IPO full review for a fundamentals-based assessment before making any grey market trades.
Manipal Health Enterprises IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Manipal Health Enterprises IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Manipal Health Enterprises IPO
Incorporated in 2010, Manipal Health Enterprises Limited is a healthcare service provider operating a large network of multi-specialty hospitals, clinics and diagnostic centres across the country. It is part of the Manipal Group, founded by T. M. A. Pai. The company offers a wide range of healthcare services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics and preventive healthcare. Its hospitals are equipped with advanced medical technology and are staffed by experienced medical professionals.
Manipal Health focuses on delivering quality, patient-centric care and expanding access to healthcare through strategic acquisitions, partnerships and continuous investment in medical infrastructure and digital health initiatives. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories, along with 21 clinics.
As of March 31, 2026, the company had 24,240 full-time employees across its hospitals and corporate functions, comprising 11,048 nurses, 6,362 paramedics and 6,830 administrative employees.
Frequently asked
What is the GMP of Manipal Health Enterprises IPO?
The current Grey Market Premium (GMP) of Manipal Health Enterprises IPO is ₹ 3.
What is the Kostak Price of Manipal Health Enterprises IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Manipal Health Enterprises IPO is not available.
What is the Subject to Sauda Price of Manipal Health Enterprises IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Manipal Health Enterprises IPO?
Manipal Health Enterprises IPO listed on August 5, 2026 at ₹652, against the issue price of ₹590 — a gain of +10.51%.
How did the GMP of Manipal Health Enterprises IPO trend before listing?
The GMP of Manipal Health Enterprises IPO was stable in its final days before listing. The GMP peaked at ₹35 on 24 July 2026. View the day-wise table above for the complete GMP history.
Explore Manipal Health Enterprises IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
